← Browse by Condition
Medical Condition
autoimmune disease
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 1
NCT06983964
Recruiting
Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
Enrollment
12 pts
Location
China
Sponsor
Beijing Boren Hospital
NCT06817889 Phase 2
Recruiting
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03816345 Phase 1
Recruiting
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...